Biologics Formulation

The creation of stable biologics formulations poses a significant challenge. Through collaborations with pharmaceutical/biotechnology R&D organizations, Freeslate has developed a new, high throughput research approach to address challenges in biologics formulation. The goal of this new approach is to develop more candidates, with more robust formulations, in a shorter period of time, with less material, and no increase in personnel. The Freeslate high throughput approach will enable you to:

Manage capacity by performing and assessing formulations much faster than you can today
Explore a much broader formulation and analytical space early in development, minimizing the increased costs associated with later stage reformulations
Bring together and manage data from orthogonal analytics to help drive informed decision making

By combining liquid dispense and controlled heating/cooling/mixing with the introduction of new high throughput capabilities for pH measurement, viscosity measurement, and visual inspection/particle counting, Freeslate has developed a single system that can support the entire formulation development process. Combined with Freeslate Lab Execution and Analysis (LEA) software, the Biologics Formulation System provides intuitive experiment design and allows for the control and data integration for a range of third party analytics including DLS, UV/Vis, cIEF, cSDS, HPLC, UPLC, etc. maximizing your R&D productivity.